Blog

Blog Grid

Diagnosis and Treatment of Heart Failure:

A Novel Clinical Decision Support System for Concordance with Expert Decision

 

One of the issues health care providers and institutions face is how to deliver evidence-based medical care at lower cost to an ever growing portion of society in need. Translation of clinical studies to everyday practice and adoption of national and international guidelines have not met expectations. This disappointing problem comes primarily from a lack of communication between ever growing and changing medical literature and individual patient profile. At the same time, threats of penalties for underperformance and poor reimbursement related to improper documentation are increasing. Therefore, transition to comprehensive clinical decision support systems (CDSS) will not just be inevitable but also rewarding.

 

In a new published article Dr. Demir Baykal, Gorica Malisanovic and Dr. Nirav Raval examine the level of correlation between the novel CDSS and health care providers’ clinical decisions.

 

Heart Failure Treatment

 

CDSS for diagnosis and treatment of heart failure (Cardiologist Evaluator) was developed using a USPO patented methodology with artificial intelligence to function as an assistant to the health care provider. It serves as a search engine to select evidence-based diagnostic and therapeutic options for a patient. A total of 389 patients with suspected heart failure were available between 2017 and 2018 at a suburban tertiary care hospital. Both Cardiologist Evaluator and health care providers gave recommendations regarding diagnosis and treatment for each patient independently. With that, the doctors went on to look into and evaluate the concordance rate between Cardiologist Evaluator recommendations and actual health care providers’ decisions. Alongside that, ICD-10 coding provided by Cardiologist Evaluator was compared to ICD-10 coding of health care provider in order to evaluate immediate cost effectiveness. Recommendations given by Cardiologist Evaluator (the heart failure treatment app) were later presented to board certified heart failure cardiologists who were then asked if they found them acceptable or unacceptable for care of each individual patient. With that, this new concordance rate between Cardiologist Evaluator and heart failure specialists was evaluated.

 

Results of the Cardiologist Evaluator

 

After the research process, the overall concordance rate between Cardiologist Evaluator recommendations and actual healthcare providers’ decisions was of 69.7%. Most discrepancies were related to adoption of new therapies, dose advancements, workup for new onset heart failure, and/or referral for LVAD. Heart failure specialists found recommendations given by Cardiologist Evaluator acceptable 99.3% of the time. Overall concordance rate between Cardiologist Evaluator and HF specialists was 98.9%. Cardiologist Evaluator provided superior, automated ICD-10 coding in order of relevance.

 

In the end, Cardiologist Evaluator shows high accuracy in evidence-based diagnosis and treatment of heart failure. It may be useful for consistent implementation of clinical guidelines and more reliable coding, especially in centers without heart failure specialists.

 

If you want to learn more, you can read the full study by clicking here.

How Medical Software Can Help End The Heart Disease Epidemic in the U.S.

How Medical Software Can Help End The Heart Disease Epidemic in the U.S.

According to data from the Center for Disease Control and Prevention, the number of deaths related to cardiovascular disease rose by almost 25,000 between 2012 and 2014. While heart disease remains the leading cause of death throughout the world, the American healthcare system has particularly abysmal records. Despite spending more than any other developed nation on cardiovascular disease, the U.S. ranks the worst in performance and patient outcomes.

Heart disease is the cause of a third of the deaths in the States, and 1 in every 6 healthcare dollars are spent on cardiovascular disease. By 2035, it is predicted that the total cost of CVD to the American healthcare system will be more than one trillion dollars, nearly double the costs in 2016. Former American Heart Association President Steven Houser even warned that “cardiovascular disease is on a course that could bankrupt our nation’s economy and health care system.”

What’s to blame for this growing and costly epidemic? And more importantly, what can be done about it?

Many Factors Influence the U.S. Heart Disease Epidemic

Like most widespread medical concerns, there is no single root cause of the cardiovascular epidemic in America. But the more we can isolate individual factors, the better we can develop a multi-faceted solution.

Here are some of the biggest challenges that our health care system needs to overcome if we are going to tackle the epidemic as a whole:

  • Nurse practitioners, physician assistants, primary care physicians, and other non-cardiologists are increasingly being called on to treat heart disease.
  • More and more patients are going to urgent care clinics rather than their PCP.
  • Rural America lacks sufficient CV specialists to meet demand.
  • Delivery of CV healthcare lacks standardization throughout the U.S.

Medical Software Promises a Solution

When PCPs, nurse practitioners, and physician assistants are forced to make clinical decisions that are traditionally meant for cardiologists, bad things are going to happen. That is precisely why the U.S. heart disease epidemic is on the rise. And since it’s impossible to have enough cardiologists to meet the growing demand of U.S. patients, technology may provide the solution America needs.

Bernard Tyson, CEO of Kaiser Permanente, the largest integrated managed care consortium in the country, argues that no “physician today should be practicing without artificial intelligence assisting in their practice. It’s just impossible (otherwise) to pick up on patterns, to pick up on trends, to really monitor care.”

Tyson’s words are ushering in a digital revolution in the world of health care, a revolution that CVD Evaluator aims to lead the charge in when it comes to combating the heart disease epidemic.

CVD Evaluator is a medical software application meant to bridge the knowledge gap between the ever growing complexity of cardiovascular treatment and the care providers who don’t have the expertise to make the right decisions. This cloud-based web and smartphone app is powered by artificial intelligence in order to guide practitioners towards evidence-based clinical decisions that have been proven to increase patient outcomes.

By drawing on the latest medical literature and machine learning technology, CVD Evaluator offers a means for standardizing the management of chronic heart disease despite the vast disparity in expertise throughout the nation. It levels the playing field for rural America and other underserved populations. Most of all, it offers an affordable, realistic way to fight back against the leading cause of death in the nation.

Blog Fulllwidth

Diagnosis and Treatment of Heart Failure:

A Novel Clinical Decision Support System for Concordance with Expert Decision

 

One of the issues health care providers and institutions face is how to deliver evidence-based medical care at lower cost to an ever growing portion of society in need. Translation of clinical studies to everyday practice and adoption of national and international guidelines have not met expectations. This disappointing problem comes primarily from a lack of communication between ever growing and changing medical literature and individual patient profile. At the same time, threats of penalties for underperformance and poor reimbursement related to improper documentation are increasing. Therefore, transition to comprehensive clinical decision support systems (CDSS) will not just be inevitable but also rewarding.

 

In a new published article Dr. Demir Baykal, Gorica Malisanovic and Dr. Nirav Raval examine the level of correlation between the novel CDSS and health care providers’ clinical decisions.

 

Heart Failure Treatment

 

CDSS for diagnosis and treatment of heart failure (Cardiologist Evaluator) was developed using a USPO patented methodology with artificial intelligence to function as an assistant to the health care provider. It serves as a search engine to select evidence-based diagnostic and therapeutic options for a patient. A total of 389 patients with suspected heart failure were available between 2017 and 2018 at a suburban tertiary care hospital. Both Cardiologist Evaluator and health care providers gave recommendations regarding diagnosis and treatment for each patient independently. With that, the doctors went on to look into and evaluate the concordance rate between Cardiologist Evaluator recommendations and actual health care providers’ decisions. Alongside that, ICD-10 coding provided by Cardiologist Evaluator was compared to ICD-10 coding of health care provider in order to evaluate immediate cost effectiveness. Recommendations given by Cardiologist Evaluator (the heart failure treatment app) were later presented to board certified heart failure cardiologists who were then asked if they found them acceptable or unacceptable for care of each individual patient. With that, this new concordance rate between Cardiologist Evaluator and heart failure specialists was evaluated.

 

Results of the Cardiologist Evaluator

 

After the research process, the overall concordance rate between Cardiologist Evaluator recommendations and actual healthcare providers’ decisions was of 69.7%. Most discrepancies were related to adoption of new therapies, dose advancements, workup for new onset heart failure, and/or referral for LVAD. Heart failure specialists found recommendations given by Cardiologist Evaluator acceptable 99.3% of the time. Overall concordance rate between Cardiologist Evaluator and HF specialists was 98.9%. Cardiologist Evaluator provided superior, automated ICD-10 coding in order of relevance.

 

In the end, Cardiologist Evaluator shows high accuracy in evidence-based diagnosis and treatment of heart failure. It may be useful for consistent implementation of clinical guidelines and more reliable coding, especially in centers without heart failure specialists.

 

If you want to learn more, you can read the full study by clicking here.

How Medical Software Can Help End The Heart Disease Epidemic in the U.S.

How Medical Software Can Help End The Heart Disease Epidemic in the U.S.

According to data from the Center for Disease Control and Prevention, the number of deaths related to cardiovascular disease rose by almost 25,000 between 2012 and 2014. While heart disease remains the leading cause of death throughout the world, the American healthcare system has particularly abysmal records. Despite spending more than any other developed nation on cardiovascular disease, the U.S. ranks the worst in performance and patient outcomes.

Heart disease is the cause of a third of the deaths in the States, and 1 in every 6 healthcare dollars are spent on cardiovascular disease. By 2035, it is predicted that the total cost of CVD to the American healthcare system will be more than one trillion dollars, nearly double the costs in 2016. Former American Heart Association President Steven Houser even warned that “cardiovascular disease is on a course that could bankrupt our nation’s economy and health care system.”

What’s to blame for this growing and costly epidemic? And more importantly, what can be done about it?

Many Factors Influence the U.S. Heart Disease Epidemic

Like most widespread medical concerns, there is no single root cause of the cardiovascular epidemic in America. But the more we can isolate individual factors, the better we can develop a multi-faceted solution.

Here are some of the biggest challenges that our health care system needs to overcome if we are going to tackle the epidemic as a whole:

  • Nurse practitioners, physician assistants, primary care physicians, and other non-cardiologists are increasingly being called on to treat heart disease.
  • More and more patients are going to urgent care clinics rather than their PCP.
  • Rural America lacks sufficient CV specialists to meet demand.
  • Delivery of CV healthcare lacks standardization throughout the U.S.

Medical Software Promises a Solution

When PCPs, nurse practitioners, and physician assistants are forced to make clinical decisions that are traditionally meant for cardiologists, bad things are going to happen. That is precisely why the U.S. heart disease epidemic is on the rise. And since it’s impossible to have enough cardiologists to meet the growing demand of U.S. patients, technology may provide the solution America needs.

Bernard Tyson, CEO of Kaiser Permanente, the largest integrated managed care consortium in the country, argues that no “physician today should be practicing without artificial intelligence assisting in their practice. It’s just impossible (otherwise) to pick up on patterns, to pick up on trends, to really monitor care.”

Tyson’s words are ushering in a digital revolution in the world of health care, a revolution that CVD Evaluator aims to lead the charge in when it comes to combating the heart disease epidemic.

CVD Evaluator is a medical software application meant to bridge the knowledge gap between the ever growing complexity of cardiovascular treatment and the care providers who don’t have the expertise to make the right decisions. This cloud-based web and smartphone app is powered by artificial intelligence in order to guide practitioners towards evidence-based clinical decisions that have been proven to increase patient outcomes.

By drawing on the latest medical literature and machine learning technology, CVD Evaluator offers a means for standardizing the management of chronic heart disease despite the vast disparity in expertise throughout the nation. It levels the playing field for rural America and other underserved populations. Most of all, it offers an affordable, realistic way to fight back against the leading cause of death in the nation.